InterCure Ltd. Form 6-K Summary
Business context and reporting period
InterCure Ltd., an Israeli foreign private issuer, filed Form 6-K for the month of October 2023. The filing was submitted on October 17, 2023, under Commission File Number 001-40614. The filing references a press release dated October 17, 2023 as Exhibit 99.1, but the press release text is not included in the provided filing content.
Financial metrics
The provided filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material changes versus the prior comparable period
No operating or financial changes versus a prior comparable period are described in the provided filing text.
Guidance, outlook, risks, and unusual items
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided filing text. These matters may be addressed in the referenced Exhibit 99.1 press release, which is not included.
Investor verification items
- Obtain and review Exhibit 99.1, the October 17, 2023 press release.
- Verify whether the press release contains financial results, guidance, operational updates, or material risk disclosures.
- Confirm any figures or statements against InterCure’s applicable Form 20-F and subsequent SEC filings.